Joining forces in the MedTech community. Prof. dr. ir. Pascal Verdonck February 10, 2015

Size: px
Start display at page:

Download "Joining forces in the MedTech community. Prof. dr. ir. Pascal Verdonck February 10, 2015"

Transcription

1 Joining forces in the MedTech community Prof. dr. ir. Pascal Verdonck February 10, 2015

2 AZ Maria Middelares Hospital Gent

3 Healthcare objective The primary goal of health care policy is to maximize the health of the population within the limits of the available resources,and within an ethical frameworkbuilt on equity and solidarity principles. Report of the Belgian EU Presidency, adopted by the EU Council of Ministers of Health in Dec

4 Patient as driver Ethics Sustainability Finances Economy Patient Technology & Science

5 Healthcare, wherein the product is a person, is complex, chaotic and fragmented due to an explosion of knowledge and technological progress! Complexity of healthcare

6 Innovation as driver Government Industry Patient Hospital

7 The Belgian National Committee on Biomedical Engineering aims to bring together the Belgian academics, master and phd students, researchers and professionals, active in Biomedical Engineering.

8 Biomedicalengineering advances knowledge in engineering, biology and medicine, andimproveshuman health through cross-disciplinary activities that integrate engineering sciences with the biomedical sciences and clinical practice

9 Biomedicalengineering

10 Online survey on medical device technology Aim: overview of medical device technology research in Belgium Survey 2011 Medical device research topics of the past, present and future Numbers of researchers / students

11 Medical devices: definition Directive 2007/47/ec defines a medical device as: any instrument, apparatus, appliance, software, material or other article, whether used alone or in combination, including the software intended by its manufacturer to be used specifically for diagnostic and/or therapeutic purposes and necessary for its proper application, intended by the manufacturer to be used for human beings.

12 Medical device research topics Biomechanics E.g. computerized gait analysis, prosthesis, artificial organs, dialysis, cardiac assist devices, stents Biomaterials E.g. testing prosthesis for toxicity, orthopedic materials (bone, meniscus), cardiovascular materials (artificial veins and stents)

13 Medical device research topics (2) Bioelectronics E.g. Body area networks for wireless monitoring, integrated wearable systems (ECG, EEG ), electronic probes for in-vivo deep brain stimulation, auditory prosthesis Medical informatics E.g. telemonitoring, electronic medical records, electronic medical prescriptions

14 Medical device research topics (3) Medical imaging E.g. computer aided diagnosis, comparative analysis of mammograms, high resolution digital histological imaging, PET/SPECT-MRI Photonics E.g. sensors to measure the polymerization of dental resin cements, implantable optical glucose sensors

15 Medical device research topics (4) Robotics E.g. intelligent prosthesis, pneumatic artificial muscles, tele-operation, steerable surgical tools for endoscopy, robotic intraocular eye surgery

16 Facts & figures Total number of researchers: 380 Total number of research groups: 38 Total number of master students: 150 Total estimated cost for medical device technology research in Belgium: 40 million per year

17 Biomedicalengineering Efficacy: does it work? Efficiency: does it help? Cost-effectiveness: does it reduce cost? Drummond et al., IJTAHC, 2008

18 TOTAL COST new medical technology less effective and more costly A D new medical technology more effective but more costly B O HEALTH EFFECT (QALY) current medical technology new medical technology cheaper but less effective C new medical technology more effective and less costly

19 Biomedicalengineering Ascher Shmulewitz et al, Nature Biotechnology, 2006

20 20

21 Swiss Med Tech value chain 21

22 Swiss Med Tech value chain - Pop universities companies - Pop universities companies

23 Swiss Med Tech value chain (CHF) Scientific research Know-How Network Financing (seed money) Invest Market Entrepreneurship Start-up Coaching Projects (years) 23

24

25

26 MedTechFlanders DevelopMedTechas animportant economical driver (MedTech) Cluster MedTech companies and activities to stimulate growth(valley) Interaction and cooperation with local (Flanders) andrelevant (inter)nationale organisations

27 Who can join? 3 DNA criteria : Companies thatproducesdevicesaccording the European MD Directive Companies that exist already Companies that have an R&D and/or decision center in Flanders

28 Objectives Facilitate existing MedTech Companies in: Internal networking and knowledge sharing External visibility Sharing of equipment and infrastructure Regulatory and Quality Affairs (QARA) Human Resources & recruitment Reimbursement Access to capital Business coaching Develop new companies/activities Merge Clinicians, technicians and entrepreneurs Bring technology and innovation bed side Reinforce the general eco-system Better support of clinical trials Systems for data collection More efficient and(cost) effective healthcare

29